DOI: 10.1093/ehjopen/oeag162 ISSN: 2752-4191

Atrial fibrillation phenotypes derived from multimodal data exhibit distinct electrophysiological substrate characteristics, symptom trajectories, and ablation outcomes

Neil Bodagh, Vinush Vigneswaran, Ali Gharaviri, Irum Kotadia, Magda Klis, Nilanka N Mannakkara, Kestutis Maciunas, Arno Von Kietzell, Megan Bell, Hayley Cuthbert, Matthew Wright, John Whitaker, Christopher A Rinaldi, Anoop Shetty, Shaumik Adhya, Gurpreet Dhillon, Roy Jogiya, Una Buckley, David Jones, Zhong Chen, Amedeo Chiribiri, Neil R Grubb, Chris Lang, Cesario Pancinha, Michelle C Williams, Steven Niederer, Shouvik Haldar, Mark O’Neill, Steven E Williams

Abstract

Background

The heterogeneity in response to catheter ablation amongst atrial fibrillation (AF) patients classified according to arrhythmia duration highlights the need for improved phenotyping. Multimodal assessment may better characterise the spectrum of pathophysiology present amongst patients classified as having paroxysmal or persistent AF.

Purpose

To perform comprehensive multimodal pre-ablation phenotyping in patients undergoing AF ablation and evaluate associations with post-ablation arrhythmia recurrence, symptom burden, and bi-atrial substrate remodelling.

Methods

In this multicentre prospective cohort study, 86 patients referred for first-time AF ablation (42% persistent AF) underwent pre-ablation phenotyping beyond usual care, incorporating patch-based ambulatory rhythm monitoring, atrial structural and functional MRI assessment, and formal symptom evaluation. Unsupervised K-means clustering was used to derive phenotypes. The primary outcome was 12-month arrhythmia recurrence; secondary analyses assessed symptom trajectories and bi-atrial substrate characteristics.

Results

Four AF phenotypes were identified. Arrhythmia recurrence occurred in 56.0%, 42.9%, 22.2%, and 19.0% of patients in Phenotypes 1–4, respectively (log-rank p=0.032). Symptom trajectories differed across phenotypes, with the greatest improvements observed in Phenotypes 3 and 4. Exploratory electroanatomic mapping analyses demonstrated significant between-phenotype differences in bi-atrial bipolar voltage aligned with clinical trajectories. Importantly, phenotypes were not fully explained by conventional classification: Phenotype 2 experienced relatively high recurrence despite comprising predominantly paroxysmal AF patients whilst Phenotype 3 demonstrated favourable outcomes despite a high prevalence of persistent AF.

Conclusions

Multimodal phenotyping identified distinct AF subgroups associated with differences in post-ablation recurrence, symptom trajectories, and electrophysiological substrate. This approach could improve pre-ablation risk stratification and shared decision-making.